SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-20-062209
Filing Date
2020-03-05
Accepted
2020-03-05 07:11:34
Documents
6
Effectiveness Date
2020-03-05

Document Format Files

Seq Description Document Type Size
1 S-8 d895311ds8.htm S-8 42988
2 EX-5.1 d895311dex51.htm EX-5.1 8287
3 EX-23.2 d895311dex232.htm EX-23.2 1628
4 GRAPHIC g895311g00z66.jpg GRAPHIC 3622
5 GRAPHIC g895311g0302161452581.jpg GRAPHIC 2009
6 GRAPHIC g895311g0302161452920.jpg GRAPHIC 1665
  Complete submission text file 0001193125-20-062209.txt   64485
Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340
Syros Pharmaceuticals, Inc. (Filer) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-236895 | Film No.: 20689620
SIC: 2834 Pharmaceutical Preparations